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Abstract
Background: Teat disinfection is an important step in the control of mastitis within a dairy herd. The objective of
this study was to evaluate the effectiveness of 96 commercially available teat disinfectant products in Ireland
against bacterial isolates on teat skin. Teat disinfection products were applied to the teats of seventeen Holstein–
Friesian cows. A split-udder model was used where one cow received two different teat disinfection products on
each day. A composite swab sample was taken of the left teats and the right teats before and after teat disinfectant
application. Swab samples were plated onto 3 different selective agars to enumerate bacterial counts of
streptococcal, staphylococcal and coliform isolates.
Results: Streptococcal isolates were the most prominent bacterial group recovered on teat swabs taken before the
application of a teat disinfection product (55.0%), followed by staphylococcal isolates (41.3%) and coliform isolates
(3.7%). Products were reclassified by active ingredients (n = 9) for analysis. These ingredient groups included;
chlorhexidine, chlorine dioxide, diamine, iodine, iodine and lactic acid, lactic acid, lactic acid and chlorhexidine,
lactic acid and hydrogen peroxide, and lactic acid and salicylic acid. The ingredient group, chlorine dioxide, resulted
in comparable reductions to the iodine group for streptococcal isolates. The ingredient group, iodine combined
with lactic acid, resulted in the greatest reduction of staphylococcal isolates. When observing products individually,
a product containing 1.6% w/w lactic acid combined with hydrogen peroxide was the most effective at reducing
streptococcal isolates on the teat skin, whereas a product containing lactic acid combined with 0.6% w/w
chlorhexidine was the most effective against staphylococcal isolates. Minor differences were observed regarding the
relationship between effectiveness and active ingredient concentration between products.
Conclusions: This study suggests that some teat disinfectant products achieve a higher reduction in bacterial levels
against different specific bacterial groups on teat skin than other products. Therefore, when choosing a teat
disinfectant product, the bacteria in the dairy herds’ environment should be considered. Further studies are
necessary to evaluate products efficacy against new IMIs and any possible effects on teat skin condition.
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Introduction
Mastitis is one of the main milk production and eco-
nomic problems facing the global industry [1] due to re-
duced milk production, the need to discard abnormal
milk or treated milk containing antibiotics, premature
culling, veterinary services and the treatment of mastitis.
Using a 70 cow herd as an example, the CostCheck cal-
culator showed a reduction in net farm profits of ap-
proximately €10,688 associated with an average herd
SCC of 200,000-300,000 cells/mL compared to a target
of 100,000–200,000 cells/mL [2]. Mastitis can also have
an adverse effect on milk quality, animal health and wel-
fare [3], an important issue to address to satisfy the One
Health approach. Many bacterial strains have been asso-
ciated with mastitis, with the main strains being identi-
fied as Streptococcus agalactiae, Streptococcus
dysgalactiae and Streptococcus uberis, Staphylococcus
aureus, and Escherichia coli [4]. In Ireland, the bacteria
associated with mastitis are Staphylococcus aureus,
Streptococcus uberis and Escherichia coli [5]. Teat disin-
fection reduces infection rates with causative agents by
reducing the bacterial load on the teat skin surface [6, 7]
and it has become a central part of the milking routine
of the modern herd [8].
Teat skin of cows can represent the source of bacterial
populations found in raw milk [9], with the rate of mas-
titis and intramammary infections (IMIs) having previ-
ously been shown to increase with increasing bacterial
numbers on the teat skin [6, 10]. Pre- and post-milking
teat disinfectants perform differently in reducing bacter-
ial transfer from the cow’s environment (i.e. bedding,
housing, yards) or between cows. Pre-milking teat disin-
fection has been shown to be effective at reducing the
incidence of mastitis caused by environmental bacteria
i.e. Str. uberis and E. coli [11, 12] and may decrease the
cow infection ratio by reducing udder bacterial contam-
ination from the environment [13]. Alternatively, post-
milking teat disinfection has been shown to reduce the
IMIs caused by contagious bacteria, such as Staphylococ-
cus aureus [14] which may have been transferred during
milking via the milkers [15] or the milking machine [16];
post-milking disinfection has proven less effective
against environmental bacteria, such as coliforms and
some streptococci species [17].
Before teat disinfectant products can be sold commer-
cially in Ireland, the product must be registered with the
Department of Agriculture, Food and Marine (DAFM)
and with the Health Products Regulatory Authority
(HPRA), and must also comply with European legisla-
tion. According to HPRA, if there are no medical claims
made, the disinfectant product intended for the applica-
tion to skin for general hygiene may be classified as a
biocide rather than as a veterinary medicine [18] and so
subject to registration under Biocidal Products
Regulation (Regulation (EU) No 528 of 2012). Within
the European Union, member states must use a com-
mon standard to evaluate teat disinfectant products.
This European standard (EN) which is known as the
BS EN 1656 can be used to compare a range of disinfec-
tants. However, there are also other laboratory and field
methods by which teat disinfectant products can be
screened. Previous studies have used modified versions
of the BS EN 1656 [19] and the disc diffusion method
[20, 21] to screen and evaluate teat disinfectant products
in short-term laboratory tests. However, laboratory
methods cannot evaluate the impact of the teat disinfect-
ant product on the bacterial load on the teat skin or effi-
cacy in reducing new IMIs. Alternatively, field tests can
evaluate the effect (positive or negative) of a teat disin-
fectant product on the reduction of new IMIs or the
bacterial load on the teat skin; field test methods include
natural exposure and teat swabbing. The natural expos-
ure protocol is suitable for application on commercial
herds and can be used to evaluate the efficacy of a teat
disinfectant product in reducing the incidence of new
IMI’s over a period of 12 weeks and over a full lactation
[22–24]. However, the practicality of this method could
be limited for testing a large number of teat disinfectants
within a certain time period. Teat swabbing has been
previously used to determine the effectiveness of a pre-
milking cleaning regime [25, 26] and also to determine
the effectiveness of teat disinfectant products in reducing
the bacterial load on teat skin surfaces [27]. This method
allows for the testing of many products over a short time
frame.
The majority of research studies in the past have been
undertaken in relation to iodine-based teat disinfectants
[28, 29]. However, the use of iodine-based products can
result in high iodine concentrations in milk, which may
concern infant formula manufacturers [30]. Further-
more, there are many new commercially available teat
disinfectant products in Ireland. These products contain
a range of active ingredients including iodine, chlorhexi-
dine, lactic acid, chlorine dioxide and salicylic acid, with
various combinations of these ingredients. The objective
of the present study was to evaluate the effectiveness of
96 commercially available teat disinfectant products of
varying ingredients and concentrations in reducing




Ninety-six commercially available teat disinfectant prod-
ucts, with different active ingredients of varying concen-
trations, were tested against bacteria, isolated from the
teat skin of Irish dairy cattle, using a teat skin swabbing
method. The teat disinfectant products were either
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ready-to-use (RTU) (n = 82) concentrate (conc.) prod-
ucts (n = 9) or required activation before use (n = 5).
Concentrate products were diluted to a usable concen-
tration, using sterile distilled water (according to the
manufacturer’s recommendation), to avoid possible is-
sues with water hardness or contaminated water. Five
chlorine dioxide products (Product number 11, 70, 89,
90 and 95) were mixed with an activator before use, ac-
cording to the manufacturer’s recommendations. The
disinfectant products used were recommended either for
both pre- and post-milking teat disinfection (n = 49),
pre-milking teat disinfection only (n = 3), or post-
milking disinfection only (n = 44). These products were
all tested under the same environmental conditions i.e.
the same milking parlour, cows, farm, climate conditions
and with the same laboratory methods to ensure com-
parable results regarding the effectiveness of the differ-
ent teat disinfectant products. Information regarding the
products used is shown in Table 1.
Test Methods
Ninety-five different teat disinfectant products were ap-
plied to the teats of spring calving Holstein-Friesian
cows from the Teagasc Moorepark research farm,
County Cork, Ireland in November 2019. This study was
approved by the Teagasc Animal Ethics Committee (ref.
TAEC168-2017). Seventeen cows, which were free from
clinical mastitis infection, were chosen for the applica-
tion of the test teat disinfectant products over a period
of nine days. These cows were housed indoors, on mat-
ted cubicle beds dressed with ground limestone daily. A
split udder design was used where each cow received
two different teat disinfectant products at each sampling
point before morning milking (one product applied to
the two left teats and a different product applied to the
two right teats). Each teat disinfectant was applied for
three test days during the trial to three different cows.
Before sampling, teats were left unprepared and swabs
(Copan Italia S.p.A Via F. Perotti, 10 25,125 Bresica – Italy)
were moistened in sterile trypticase soy broth (TSB) (Merck
Millipore, Ireland) to aid in the recovery of bacteria from
the teat skin. A swab sample was then taken to enumerate
the number of bacteria on the unprepared teat skin (PRE).
A separate swab was used to collect a composite sample
from the left teats (left front [LF] and left hind [LH]) while
a separate swab was used to collect a composite swab sam-
ple from the right teats (right front [RF] and right hind
[RH]). Teat disinfectant products were applied using non-
return teat dip cups and the teats were immersed in the
product. One product was applied to the 2 left teats of the
cow and the other product applied to the remaining 2 teats
on the right side. To standardise the evaluation of all prod-
uct types, teats were wiped with an individual disposable
paper towel, after approximately 1 min of disinfectant
contact time. Two swabs were then used (one swab for LF
and LH teats and one swab for RF and RH teats) to obtain
a count of the bacteria left on the teats (POST).
The wiping of teats with an individual paper towel one
minute after the application of disinfectant and before
post swab samples was required to remove excess teat
disinfectant from the teat skin. To establish if the appli-
cation of a wet substance followed by drying with paper
towels had any impact on the bacterial levels recovered,
sterile phosphate-buffered saline (PBS) was applied onto
the teat skin using a sterile dip cup; after one minute the
teats were dried using individual paper towels. Sampling
was carried out in the same manner as the teat disinfec-
tants above. This was carried out prior to the com-
mencement of the current study to determine the
possible reduction of bacterial load due to the presence
of a liquid solution and wiping action.
Teat swabbing involved drawing the swabs across the
teat orifice and down the side of each teat avoiding con-
tact with the udder hair or cows flank at all times. Teat
swabbing was carried out by the same two operators for
all treatments. In all, sampling provided 576 individual
teat swab samples (96 products x 2 swabs/day x 3 test
days), giving a total of 3 before and 3 after swab samples
per treatment. Immediately after sampling, swabs were
placed into individual sterile bottles containing 10 mL of
sterile TSB and neutraliser (30 g/L polysorbate 80 & 3 g/
L l-a-phosphatidylcholine from egg yolk). The TSB and
neutraliser were prepared in 250 mL lots and autoclaved
at 121 ˚C for 15 min, and then distributed into 10 mL
aliquots in a laminar flow cabinet. The sterile bottles
(containing TSB, neutraliser and swab) were placed in
storage at -20 ˚C until analysed for the presence of
staphylococcal and streptococcal isolates.
Before the start of analysis, the sterile bottles were
defrosted and vigorously shaken on a vortex. To meas-
ure bacterial levels, dilutions of 1:100 were performed
for the PRE samples using maximum recovery diluent in
sterile tubes. The POST samples were used undiluted.
The samples were subsequently plated, in triplicate, onto
three separate agars; Baird parker agar (Merck
KGaA64271, Darmstadt, Germany) with the addition of
egg yolk tellurite emulsion for staphylococcal isolates,
modified Edwards agar (Oxoid 3M0027) with 5% sterile
sheep blood for streptococcal isolates and MacConkey
agar (Merck Millipore, Ireland) for coliform isolates.
Specific bacteria types within each category were not de-
fined. Following incubation at 37 ˚C for 24 hrs, micro-
bial counts for each isolate type were manually counted.
Statistical Analysis
Statistical analysis was carried out using SAS for Win-
dows, version 9.4. Bacterial counts (cfu/mL) were trans-
formed to base-10 logarithm for analysis. Teat
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disinfectant effectiveness was defined as the Log10 per-
cent reduction from the PRE swab for each teat disin-
fectant product using the following equation [28, 31].
Log10 reduction refers to the difference between the
Log10 values of PRE and POST swabs. The application
of sterile PBS and teat wiping resulted in a reduction
of 0.8% for streptococcal isolates and 0.3% for
staphylococcal isolates. These values were subtracted,
according to isolate group, from the results obtained
for each individual teat disinfectant product to ac-
count to the effect of the liquid applied and wiping
action used in the study. PROC GLIMMIX was used
to perform multiple pair-wise comparisons. The
LSMEANS statement in PROC GLIMMIX was used
to differentiate statistical differences. Products used
within the study were categorised into groups based
on the active ingredient (n = 9) to minimise/control
the occurrence of Type II errors during analysis.
These groups included; chlorhexidine (n = 25), chlor-
ine dioxide (n = 5), diamine (n = 1), iodine (n = 13),
iodine combined with lactic acid (n = 5), lactic acid
(n = 15), lactic acid combined with chlorhexidine (n =
21), lactic acid combined with hydrogen peroxide
(n = 1), and lactic acid combined with salicylic acid
(n = 10). Products within the active ingredient group
were compared to each other. The reductions for
each bacterial isolate tested were analysed separately
using the same model. This model included the Log10
percentage reductions as a dependant variable, and
product within the active ingredient group and day as
independent variables. The equation for the model
was as follows; Reduction = Product + Bacteria + Day +
Product X Bacteria, where reduction was the Log10
percentage reduction, where product was the teat dis-
infectant product tested and day was the date of sam-
pling. The cow was the experimental unit. Differences
between ingredient groups were analysed using the
following model; Reduction = Ingredient + Bacteria +
Day + Ingredient X Bacteria. Residual checks were
made to ensure assumptions of analysis were met.
Results
Streptococcal isolates were the most prominent bacterial
group recovered on PRE teat swabs (55.0%), followed by
staphylococcal isolates (41.3%) and coliform isolates
(3.7%) (Fig. 1). The level of coliform isolates recovered
was low and therefore not included in further analysis
within this study. All teat disinfectant products tested
had a positive effect on reducing the bacterial load on
the teat skin. For streptococcal isolates, average Log10
bacterial reduction on teat skin was 36.6%. For staphylo-
coccal isolates, average Log10 bacterial reduction on teat
skin was 44.1%. Additionally, a sampling day and a day
by product effect was observed within the data which
shows there was a day to day variation of the level of
bacterial contamination on teat skin.
Within the study, there were nine ingredient groups
created based on active ingredient: chlorhexidine, chlor-
ine dioxide, diamine, iodine, iodine combined with lactic
acid, lactic acid, lactic acid combined with chlorhexidine,
lactic acid combined with hydrogen peroxide, and lactic
acid combined with salicylic acid. Bacterial isolate LS-
means percentage log reductions achieved by products
within ingredient groups are summarised in Fig. 2. For
two ingredient groups analysed, there was one only one
product analysed per group. These ingredient groups in-
cluded diamine and lactic acid combined with hydrogen
peroxide. While it is recognised that these two groups
had a limited amount of products, these groups achieved
some of the greatest reductions in streptococcal and
staphylococcal isolates. For streptococcal isolates, the in-
gredient group that contained a combination of lactic
acid and hydrogen peroxide resulted in the largest bac-
terial reductions (89.9%). Lactic acid combined with
chlorhexidine group resulted in the smallest bacterial re-
duction of 30.2%. For staphylococcal isolates, the ingre-
dient group diamine resulted in a reduction of 94.7%,
whereas, chlorine dioxide resulted in the smallest reduc-
tion of staphylococcal isolates (39.0%). The LS-means
Log10 percentage (%) reduction for streptococcal and
staphylococcal isolates for each individual product can
be observed in Table 1.
For both streptococcal and staphylococcal isolates, no
significant difference was observed between chlorine di-
oxide, iodine, chlorhexidine or lactic acid only. For
streptococcal isolates, chlorine dioxide (47.5%) had nu-
merically higher bacterial reductions than chlorhexidine
(33.5%) and iodine (35.3%). Additionally, lactic acid
combined with chlorhexidine resulted in the lowest
overall reduction (30.2%) for streptococcal isolates. A
combination of iodine and lactic acid was found to be
the most effective (54.0%) against staphylococcal isolates,
with chlorine dioxide resulting in a lower reduction
(39.0%) which was not significantly different (P > 0.05).
Despite products not being compared individually, it is
possible to observe the most effective teat disinfectant
product against both streptococcal and staphylococcal
isolates. For streptococcal isolates, product 46 (1.6% w/w
lactic acid and hydrogen peroxide), product 23 (2% w/w
lactic acid and 0.1% w/w salicylic acid) and product 83
(0.5% w/w iodine) resulted in the highest percentage log
reductions of 89.9%, 77.6% and 73.7%, respectively.
For staphylococcal isolates, products containing 2%
lactic acid combined with 0.6% w/w chlorhexidine
(product 47), 0.6% w/w diamine (product 26) and
chlorhexidine only (product 61) resulted in the high-
est percentage log reductions of 100%, 94.7% and
82.5%, respectively.
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Table 1 LS-means of Log10 percentage reduction (%) for each teat disinfection product, within each ingredient group, against
streptococcal and staphylococcal isolates
Product # Ingredient (w/w) 1 Pre or Post Strep Isolates Staph isolates
Chlorhexidine Products
Arrabawn Udder Guard^ 40 0.5% Chlorhexidine Pre & Post 65.7 a 56.8 a,b
C-Dip^ 61 0.53% Chlorhexidine Post 19.8 a,b 82.5 a
Deosan Mastocide^ 32 0.5% Chlorhexidine Post 30.4 a,b 54.6 a,b
Deosan Summer Teat Care^ 33 0.425% Chlorhexidine Post 15.6 a,b 25.6 b
Deosan Teat Foam Advance^ 13 0.6% Chlorhexidine Pre & Post 26 a,b 36.5 a,b
Deosan Teatcare Plus^ 14 0.425% Chlorhexidine Post 30.3 a,b 31. a,b
Hamra Red^ 12 0.42% Chlorhexidine Post 20.1 a,b 33.5 a,b
Hexa-cel RTU^ 42 0.52% Chlorhexidine Pre & Post 61.4 a 53.1 a,b
Hexaguard^ 1 0.74% Chlorhexidine Pre & Post 22.7 a,b 33.6 a,b
Hexaklene R^ 2 0.5% Chlorhexidine Pre & Post 58.5 a 32.5 a,b
Hexa-Spray^ 82 0.5% Chlorhexidine Pre & Post 44.6 a,b 49.3 a,b
Kenocidin Spray & Dip^ 9 0.5% Chlorhexidine Post 13.1 b 33.5 a,b
Kenomint^ 77 0.5% Chlorhexidine Post 16.4 a,b 24.9 b
Kenomint SD^ 78 0.5% Chlorhexidine Post 36.6 a,b 31.8 a,b
Masodip Platinum^ 84 0.436% Chlorhexidine Pre & Post 30.2 a,b 35.3 a,b
PureChem Chlorhexidine^ 48 1.49% Chlorhexidine Post 17.0 a,b 43.7 a,b
PureChem Chlorhexidine Summer grade^ 52 1.49% Chlorhexidine Pre & Post 54.4 a,b 50.6 a,b
Quatro^ 41 0.5% Chlorhexidine Pre & Post 36.8 a,b 31.4 a,b
SensoDip^ 16 0.5% Chlorhexidine Pre & Post 16.1 a,b 30.9 a,b
Sensodip 50^ 72 0.5% Chlorhexidine Post 24.7 a,b 18.8 b
Sensospray^ 66 0.5% Chlorhexidine Post 45.8 a,b 47.1 a,b
Summer C-Dip^ 58 0.5% Chlorhexidine Post 42.1 a,b 56.9 a,b
Supergold^ 18 0.5% Chlorhexidine Pre & Post 42.6 a,b 59.6 a,b
Surespray^ 5 0.5% Chlorhexidine Pre & Post 24.4 a,b 55.6 a,b
Teat Gard C^ 63 0.5% Chlorhexidine Pre & Post 42.5 a,b 50.1 a,b
Chlorine Dioxide Products
Bisept* 70 0.05% Chlorine dioxide Pre & Post 46.7 a 38.2 a
Kenomix* 11 0.0157% Chlorine dioxide Post 61.3 a 51.0 a
Kenomix SD* 89 0.0157% Chlorine dioxide Post 57.5 a 14.0 a
Uddergold* 90 0.32% Acidified sodium chlorite Post 30.3 a 18.6 a
Valiant* 95 0.038% Sodium chloride Post 35.3 a 36.2 a
Diamine Products
Super Cow Teat Foam^ 26 0.6% Diamine Pre & Post 72.2 94.7
Iodine Products
D 4 Iodine+ 19 0.5% Iodine Post 10.5 b 35.1 a,b
Deosan Super Iodip+ 34 0.5% Iodine Post 51.4 a,b 39.3 a,b
Ioguard+ 3 0.5% Iodine Post 51.8 a,b 55.8 a,b
Ioklar Multi^ 92 0.25% Iodine Pre & Post 35.7 a,b 44.4 a,b
Io-Shield D^ 91 1.35% Iodine Post 39.0 a,b 13.3 b
Io-Shield Spray^ 93 0.5% Iodine Post 12.8 a,b 50.1 a,b
Luxdip 50B^ 69 0.5% Iodine Post 37.0 a,b 55.9 a,b
Masocare Platinum^ 85 0.54% Iodine Pre & Post 33.7 a,b 34.7 b
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Table 1 LS-means of Log10 percentage reduction (%) for each teat disinfection product, within each ingredient group, against
streptococcal and staphylococcal isolates (Continued)
Product # Ingredient (w/w) 1 Pre or Post Strep Isolates Staph isolates
Masodine 1:3 Concentrate+ 83 0.5% Iodine Pre & Post 73.7 a 78.1 a
Maxadine C+ 8 0.5% Iodine Post 34.9 a,b 38.9 a,b
Maxidine RTU^ 37 0.5% Iodine Post 55.3 a,b 35.5 a,b
PureChem Iodophor+ 50 0.5% Iodine Post 27.7 a,b 52.2 a,b
Silkdip+ 24 0.5% Iodine Post 28.1 a,b 65.3 a,b
Iodine and Lactic Acid Products
Gold Glycodip XL^ 62 0.5% Iodine & 1% L-(+)-lactic acid Post 71.0 a 75.9 a
Lanodip 4 XL^ 30 0.5% Iodine & 0.5% L-(+)-lactic acid Post 55.7 a 29.6 a
Lanodip Pre-Post^ 55 0.29% Iodine & 0.8% L-(+)-lactic acid Pre & Post 30.1 a,b 48.4 a
TriCide^ 56 0.15% Iodine & 1% L-(+)-lactic acid Post 34.7 a 47.1 a
TriCide Gold^ 57 0.15% Iodine & 1% L-(+)-lactic acid Pre & Post 12.0 b 53.1 a
Lactic Acid Products
Barri-max^ 65 2.4% L-(+)-lactic acid Post 50.7 a,b 52.3 a
Blu-gard N Spray^ 15 3.46% L-(+)-lactic acid Post 40.2 a,b 49.2 a
Dairy Pro Ultra Dip^ 74 3% L-(+)-lactic acid Post 24.9 a,b 28.0 a
DairyLac SA^ 76 3% L-(+)-lactic acid Post 3.2 b 28.0 a
Deosan Triathalon^ 81 1.76% L-(+)-lactic acid Pre & Post 41.9 a,b 35.2 a
Flexigard Spray^ 94 4% L-(+)-lactic acid Post 60.9 a,b 38.3 a
Kenolac^ 10 3.6% L-(+)-lactic acid Post 47.5 a,b 42.5 a
Kenolac SD^ 80 3.6% L-(+)-lactic acid Post 16.8 a,b 17.5 a
Kenopure^ 79 3.2% L-(+)-lactic acid Pre 36.8 a,b 21.5 a
Lacto-cel^ 35 2.4% L-(+)-lactic acid Pre & Post 55.8 a,b 59.7 a
Lacto-Mil^ 96 5% L-(+)-lactic acid Pre & Post 70.1 a 66.9 a
Lactospray^ 4 2.4% L-(+)-lactic acid Pre & Post 54.1 a,b 59.0 a
Salvodip B^ 71 2.4% L-(+)-lactic acid Post 46.4 a,b 32.9 a
Salvospray^ 68 2.4% L-(+)-lactic acid Pre & Post 37.0 a,b 45.5 a
Synofilm^ 88 8% L-(+)-lactic acid Post 42.3 a,b 36.0 a
Lactic Acid and Chlorhexidine Products
Arkshield^ 7 5% L-(+)-lactic acid & 0.3% Chlorhexidine Pre & Post 43.4 a,b 64.1 a,b,c,d
Bacto-Lac^ 31 5% L-(+)-lactic acid & 0.05% Chlorhexidine Pre & Post 4.3 a,b 13.0 d,e
Blue Barrier Spray^ 49 2% L-(+)-lactic acid & 0.6% Chlorhexidine Post 54.1 a 78.6 a,b
Co-op Source Duo Teat Shield^ 39 2% L-(+)-lactic acid & 0.3% Chlorhexidine Pre & Post 0.4 b 60.7 a,b,c,d
Dual Dip^ 45 2% L-(+)-lactic acid & 0.3% Chlorhexidine Pre & Post 30.0 a,b 56.3 b,c,d,e
Dual Dip Supreme^ 47 2% L-(+)-lactic acid & 0.6% Chlorhexidine Pre & Post 50.7 a,b 100 a
Duo-cel^ 38 2.5% L-(+)-lactic acid & 0.3% Chlorhexidine Pre & Post 46.6 a,b 64.5 a,b,c,d
Duogold^ 17 2% L-(+)-lactic acid & 0.3% Chlorhexidine Pre & Post 18.6 a,b 41.8 b,c,d,e
Duo-Teat Shield^ 25 2% L-(+)-lactic acid & 0.3% Chlorhexidine Pre & Post 10.6 a,b 11.4 d,e
Fortress Protect Film^ 73 3% L-(+)-lactic acid & 0.2% Chlorhexidine Post 18.9 a,b 51.6 b,c,d,e
Hypraspray^ 87 2% L-(+)-lactic acid & 0.03% Chlorhexidine Pre & Post 0.6 b 22.4 c,d,e
Lacto dual^ 36 2.5% L-(+)-lactic acid & 1.5% Chlorhexidine Pre & Post 6.0 a,b 16.6 d,e
Nano Dual^ 28 1.93% L-(+)-lactic acid & 0.2% Chlorhexidine Pre & Post 49.4 a,b 52.0 b,c,d,e
Novo Dual^ 29 4% L-(+)-lactic acid & 0.27% Chlorhexidine Pre & Post 26.5 a,b 27.8 c,d,e
Novodip^ 60 4.9% L-(+)-lactic acid & 1.28% Chlorhexidine Post 45.3 a,b 7.8 e
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Chlorhexidine
In the study, the chlorhexidine ingredient group was
the largest, with 25 different products containing
various concentrations of chlorhexidine (range: 0.42%
w/w to 1.49% w/w chlorhexidine) (Table 1). For
streptococcal isolates, product 40 (0.5% w/w chlor-
hexidine) obtained the largest bacterial reduction of
65.7%, significantly greater than product 9 (13.1%)
(0.5% w/w chlorhexidine) (P < 0.05). For staphylococ-
cal isolates, Product 61 (0.53% w/w chlorhexidine)
resulted in the greatest reduction of 82.5%, signifi-
cantly greater than product 72 (18.8%) (0.5% w/w
chlorhexidine) (P < 0.05).
Chlorine Dioxide
Overall, 6 different chlorine dioxide-based products,
with concentrations of chlorine dioxide ranging from
0.0157% w/w to 0.32% w/w were tested. No significant
differences were observed for both streptococcal and
staphylococcal isolates among chlorine dioxide products.
For streptococcal isolates, product 11 (0.0157% w/w
chlorine dioxide) resulted in the numerically largest bac-
terial reduction of 61.3% (Table 1). Additionally, product
11 resulted in the numerically greatest bacterial
reduction of 51.0% for staphylococcal isolates. Chlorine
dioxide products also resulted in reductions comparable
to iodine for streptococcal isolates.
Diamine
Just one product tested contained the ingredient diamine
(product 27; 0.6% w/w diamine). This product resulted
in a bacterial reduction of 72.2% and 94.7% for strepto-
coccal and staphylococcal isolates, respectively (Table 1).
Iodine
Thirteen different iodine products of varying concentra-
tions (range: 0.5% w/w to 1.35% w/w iodine) were tested
on the teat skin to determine their bacterial reduction.
For streptococcal and staphylococcal isolates, product 83
(0.5% w/w iodine) resulted in the largest bacterial reduc-
tion of 73.7% and 78.1%, respectively (P < 0.05)
(Table 1).
Iodine and Lactic Acid
In the study, 5 products which contained a combination
of iodine and lactic acid were tested. Minor differences
in effectiveness were observed within this ingredient
group regarding the concentration levels of active
Table 1 LS-means of Log10 percentage reduction (%) for each teat disinfection product, within each ingredient group, against
streptococcal and staphylococcal isolates (Continued)
Product # Ingredient (w/w) 1 Pre or Post Strep Isolates Staph isolates
Novospray^ 54 4.9% L-(+)-lactic acid & 0.3% Chlorhexidine Post 44.6 a,b 32.8 b,c,d,e
Protect Pre Post^ 75 3% L-(+)-lactic acid & 0.25% Chlorhexidine Pre & Post 46.2 a,b 71.8 a,b,c
PureChem Dual Dip^ 51 1% L-(+)-lactic acid & 1.49% Chlorhexidine Pre & Post 9.1 a,b 62.9 a,b,c,d
Salvohex^ 67 2% L-(+)-lactic acid & 0.3% Chlorhexidine Post 32.8 a,b 44.9 b,c,d,e
Supreme^ 64 2.5% L-(+)-lactic acid & 0.375% Chlorhexidine Pre & Post 28.3 a,b 51.3 b,c,d,e
Sure spray Duo^ 6 2% L-(+)-lactic acid & 0.3% Chlorhexidine Pre & Post 40.6 a,b 81.6 a,b
Lactic Acid and Hydrogen Peroxide Products
Lactic Lather^ 46 1.6% L-(+)-lactic acid & hydrogen peroxide Pre 89.9 59.4
Lactic Acid and Salicylic Acid Products
Biolac PrePost^ 59 0.25% L-(+)-lactic acid & 0.03% Salicylic acid Pre & Post 34.6 a,b 48.7 a,b
Dermalac Emprasan^ 27 0.25% L-(+)-lactic acid & Salicylic acid Pre & Post 4.6 b 18.3 b
Emprasan dual^ 53 0.25% L-(+)-lactic acid & Salicylic acid Pre & Post 53.9 a,b 53.1 a
Hypred Quick Spray^ 20 2% L-(+)-lactic acid & 0.1% Salicylic acid Pre & Post 35.0 b 37.9 a,b
Lely Quaress-Cura^ 43 3% L-(+)-lactic acid & Salicylic acid Post 31.3 a,b 33.3 a,b
Prefoam+^ 21 2% L-(+)-lactic acid & 0.1% Salicylic acid Pre 25.1 b 37.9 a,b
Virolac Concentrate+ 22 2% L-(+)-lactic acid & 0.1% Salicylic acid Pre & Post 32.3 a,b 35.0 a,b
Virolac Film^ 23 2% L-(+)-lactic acid & 0.1% Salicylic acid Post 77.6 a 49.6 a
Virolac Spray^ 86 2% L-(+)-lactic acid & 0.1% Salicylic acid Pre & Post 53.1 a.b 44.0 a,b
^RTU+Concentrate *Requires activation before used
1 Ingredient/working solution as declared by the manufacturer
a −e Inhibition not sharing the same superscript in a column within an ingredient group were significantly different (P < 0.05)
Teat disinfection products listed is not an indication of the regulatory status of the products. Check the department of Agriculture, Food and Marine (DAFM)
Biocidal Products Register (http://www.pcs.agriculture.gov.ie/registers/biocidalproductregisters/) and Health Products Regulatory Authority (HPRA) (http://www.
hpra.ie/homepage/veterinary) before purchase
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ingredients within products. These products ranged
from concentrations of 0.15% w/w iodine combined
with 0.8% w/w lactic acid to 0.5% w/w iodine com-
bined with 1% w/w lactic acid. Product 62 (0.5% w/w
iodine combined with 1% w/w lactic acid) resulted in
the largest bacterial reduction of 71.0% in comparison
to product 57 (12.0%) (0.15% w/w iodine combined
with 1% w/w lactic acid) for streptococcal isolates
(P < 0.05). Similar to streptococcal isolates, product 62
resulted in the largest bacterial reduction of 75.3% for
staphylococcal isolates, which was significantly differ-
ent to product 30 (29.6%) (0.5% w/w iodine combined
with 0.5% w/w lactic acid) (P < 0.05). For staphylococ-
cal isolates, the ingredient group, iodine and lactic
acid, resulted in bacterial reductions comparable to
iodine.
Lactic Acid
Fifteen products tested contained lactic acid as the main
active ingredient. These products ranged from concen-
trations of 1.76% w/w to 8% w/w lactic acid. No signifi-
cant differences were observed between lactic acid
products for staphylococcal isolates. For streptococcal
isolates, product 96 (5% w/w lactic acid) resulted in the
numerically largest bacterial reduction of 70.1%.
Lactic Acid and Chlorhexidine
The second largest ingredient group consisted of 21
products which contained a combination of lactic acid
and chlorhexidine. These products ranged in concentra-
tions of 1% w/w lactic acid combined with 0.03% w/w
chlorhexidine to 5% w/w lactic acid combined with
1.49% w/w chlorhexidine. Among the lactic acid
Fig. 1 Overall Log10 bacterial counts for streptococcal, staphylococcal and coliform isolates on teat swabs before (PRE) and after (POST) the
application of teat disinfection products. a-f Means with different letters differ significantly. Error bars indicate SEM
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combined with chlorhexidine products tested, product
49 (lactic acid combined with 0.6% w/w chlorhexidine)
resulted in the largest bacterial reduction of 54.1%
against streptococcal isolates, which was significantly
greater than product 39 (0.4%) (2% w/w lactic acid com-
bined with 0.3% w/w chlorhexidine) (P < 0.05). Product
47 (2% lactic acid combined with 0.6% w/w chlorhexi-
dine) obtained the largest bacterial reduction of 100%
against staphylococcal isolates.
Lactic Acid and Hydrogen Peroxide
One teat disinfection product within the 96 products
tested contained a combination of lactic acid and hydro-
gen peroxide. Product 46 (1.6% w/w lactic acid com-
bined with hydrogen peroxide) was found to result in
bacterial reductions of 89.9% and 59.4% for streptococcal
and staphylococcal isolates, respectively.
Lactic Acid and Salicylic Acid
A total of 10 products containing a combination of lactic
acid and salicylic acid were tested. These products
ranged from concentrations of 0.5% w/w lactic acid
combined with 0.03% w/w salicylic acid. For streptococ-
cal isolates, product 23 (2% w/w lactic acid combined
with 0.1% w/w salicylic acid) resulted in the numerically
largest bacterial reduction of 77.6%. For staphylococcal
isolates, product 53 (0.25% w/w lactic acid combined
with salicylic acid) resulted in the largest bacterial
reduction of 53.1%, which was significantly different to
product 27 (18.3%) (0.25% w/w lactic acid combined
with salicylic acid) (P < 0.05).
Discussion
In the current study, streptococcal isolate numbers on
teat skin were higher than those observed for staphylo-
coccal isolates. This may be due to the fact that cows
were housed indoors during the study. Bedding material
can often serve as a point of exposure to environmental
organisms, as bedding materials may contain different
distributions of microorganisms [32]. Despite the fact
that Staphylococcus aureus has been identified as the
most common subclinical mastitis related pathogen on
dairy farms in Ireland [33], a study by Keane et al. [5]
found a higher frequency of Strep uberis isolated in clin-
ical milk samples collected from 30 dairy herds in
Ireland compared to Staph. aureus.
The day by day variation in naturally present bacterial
levels observed on the teat skin would be expected as
environmental factors can affect the level of naturally
occurring bacterial contamination of the teat skin sur-
face [34, 35]. This may be a limitation of the teat swab-
bing method as results may vary due to the natural
fluctuations in bacterial levels present on the teat skin.
Previous studies have tested pre-milking teat disinfect-
ant products on the teat skin surface by allowing a con-
tact time of 15 s [26] or 30 s [25]. A study by Lopez-
Fig. 2 LS-means of the percentage Log10 reduction (%) of streptococcal and staphylococcal isolates across all active ingredients tested on the
teat skin. Error bars indicates SEM. Percentage log reduction (%) determined from Log10 PRE swab values.
a-dMeans with different letters
differ significantly
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Benavides et al. [19], used contact times of 15 s, 30 s
and two minutes in a modified version of the BS EN
1656 method found that teat disinfectant products
(hydrogen peroxide and chlorine dioxide; recommended
for pre- and post-milking disinfection) achieved the re-
quired log reduction of greater than 5 against a range of
mastitis-causing bacteria within 15 s and 30 s. In the
current study, a contact time of one minute was chosen
to test both pre- and post-milking teat disinfectant
products.
Concentrations of specific ingredients did not always
result in the highest level of bacterial reduction as would
be expected. While commercially available teat disinfect-
ant products may appear to use similar and/or different
concentrations of active ingredients, the levels and
strengths of additional ingredients such as emollients
may influence the effectiveness of a teat disinfection in-
gredient [36], while improving teat condition [37]. Lim-
ited information concerning emollient levels in products
was available; therefore, the impact of those ingredients
on teat condition could not be evaluated.
Iodine has been proven to be an effective teat disin-
fectant against staphylococcal species in both laboratory
and field studies [23, 28, 29]. A wide range of new prod-
uct types and combination of ingredients are now avail-
able for teat disinfection. In a previous study, iodine
combined with lactic acid and a lactic acid (2.4%) only
product achieved a 73% and 79% reduction of naturally
present staphylococcal isolates, respectively, on the teat
skin, as compared to 76% obtained by an iodine only
product [27]. In the current study, the ingredient group
iodine combined with lactic acid and lactic acid only
achieved reductions which were comparable to the in-
gredient group, iodine.
Furthermore, iodine has been very effective against
streptococcal species in previous studies. A study evalu-
ating the application of iodine to the teat skin found that
streptococci species were reduced by 89.77% and no
statistical difference was observed in effectiveness be-
tween different concentrations [40]. Results of the
current study agree with Enger et al. [28] who observed
log reductions of 86.4% and 96.2% for Str. uberis and
Str. dysgalactiae, respectively, when a 0.5% iodophor teat
disinfectant product was applied in an excised teat test
method. Products containing various levels of lactic acid
have been shown to be comparable to iodine against
streptococcal isolates in the current study. Previous
studies have demonstrated lactic acid to be effective
against streptococcal bacteria. A foaming solution con-
taining lactic acid only significantly reduced Str. uberis
on the teat skin with the same product having a reduc-
tion of 3.5 times on colonies on the teat skin [12]. Add-
itionally, a 2% lactic acid combined with 0.1% salicylic
acid product achieved a cfu/mL reduction of 63% against
streptococcal isolates naturally present on the teat skin
[27].
In the present study, a chlorhexidine only teat disin-
fectant product achieved one of the highest log reduc-
tions (82.5%) against staphylococcal isolates on the teat
skin. Teat disinfectant products containing chlorhexidine
have been previously demonstrated to be effective at re-
ducing staphylococcal counts on teat skin [27, 39]. A
chlorhexidine product was shown to be 4.46 times more
likely to reduce the staphylococcal counts on teat skin in
comparison to wash and drying [40]. In a previous study,
a 0.5% chlorhexidine resulted in a reduction of 93%, with
a product containing 2% lactic acid combined with 0.3%
chlorhexidine resulting in a reduction of 71% respect-
ively against naturally present staphylococcal isolates on
the teat skin [27].
Within the study, two ingredient groups only included
one product each. These ingredient groups were diamine
and lactic acid combined with hydrogen peroxide. Au-
thors recognise that this may not allow for an accurate
comparison of these ingredient groups against the other
seven ingredient groups. However, these individual prod-
ucts resulted in some of the highest bacterial reductions
for each bacterial isolate group. Diamine was found to
be the most effective against staphylococcal isolates. Fur-
thermore, this product was previously tested using the
disc diffusion method and resulted in some of the lowest
zones of inhibition against Staph. aureus (ATCC® 6538™)
(Unpublished work, 2020). This ingredient has been
known to be stable at a wide range of pH and effective
in the presence of heavy organic soiling [41] which may
explain why the ingredient was less affected by the or-
ganic matter present on teat skin in comparison to other
ingredients. Lactic acid combined with hydrogen perox-
ide was the most effective against streptococcal isolates
with a percentage log reduction of 89.9%. A previous
study by Enger et al. [28] which used the excised teat
method to determine the effect of a 1% hydrogen perox-
ide (H2O2) against two streptococcus strains (Str. dysga-
lactiae and Str. uberis) found that this product achieved
a high kill effect within 15 s of contact time compared
with iodophor products tested. This was also demon-
strated by Lopez-Benavides et al. [19] who found that
two products, which both contained 0.5% hydrogen per-
oxide, achieved a > 5 log reduction in a modified BS EN
1656 method. However, at present, hydrogen peroxide
has been mainly used in the dairy industry for the clean-
ing of milking machines and bulk milk tanks. Due to the
ingredients history, the prolonged use and concentration
of this ingredient within teat disinfectant may have a
negative impact on teat skin condition; therefore, the in-
clusion of the ingredient in a teat disinfectant product
must be thoroughly tested to determine its effect on teat
skin condition.
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The results showed that the ingredient groups; chlor-
ine dioxide, iodine combined with lactic acid and lactic
acid only, achieved high bacterial reductions for strepto-
coccal isolates. Whereas, the ingredient groups iodine
combined with lactic acid, iodine only and lactic acid
combined with chlorhexidine resulted in large bacterial
reductions against staphylococcal isolates. However, the
individual products containing a combination of lactic
acid hydrogen peroxide and lactic acid combined with
salicylic acid resulted in the largest bacterial reductions
for streptococcal isolates, with products containing a
combination of lactic acid and 0.6% w/w chlorhexidine
and diamine resulting in the largest bacterial reductions
for staphylococcal isolates.
Teat skin condition was not evaluated in this study as
products were not applied for a sufficient period of time
to have allowed a correct assessment of each individual
teat disinfectant products effect on teat skin condition.
However, teat skin condition is important and can be
regarded as a vital aspect of teat disinfection [38], thus
further research must be performed for each individual
product used in the study to determine their impact.
Conclusions
To our knowledge, this is the first reported study to per-
form an independent analysis of the effectiveness of vari-
ous teat disinfectant products which are commercially
available in Ireland against bacterial isolates naturally
present on teat skin in an Irish dairy herd. No statistical
difference was observed between the iodine, chlorhexi-
dine or lactic acid groups for both staphylococcal and
streptococcal isolates. When products were observed in-
dividually, two products (product 46 and product 26)
were amongst the most effective for both streptococcal
and staphylococcal isolates. This study suggests that
some teat disinfectant products achieve a higher reduc-
tion in bacterial levels against different specific bacterial
groups on teat skin than other teat disinfectant products.
Therefore, when choosing a teat disinfectant product,
the bacteria in the dairy herds’ environment should be
considered. No relationship was observed between a
higher concentration of active ingredient and increased
effectiveness. Further studies must be performed to
evaluate products efficacy against new IMIs and any pos-
sible effects on teat skin condition.
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